ICON study: A phase 2 study of CC220 (iberdomide) combined with low-dose cyclophosphamide and dexamethasone in relapsed/refractory multiple myeloma (IberCd)
DUET2: Azole-echinocandin combination therapy for invasive aspergillosis. A randomized pragmatic superiority trial
ReSPECT: A phase 3, multicenter, randomized, double-blind study of the efficacy and safety of rezafungin for injection versus the standard antimicrobial regimen to prevent invasive fungal diseases in adults undergoing allogeneic blood and marrow transplantation
HISTORY: Hypoplasminogenemia: an international retrospective and prospective cohort study
OPTI-CLOT: To WiN: Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease
SCORE: Sickle cell outcome research
Sickle cell screen: Investigating red blood cell deformability of sickle cell patients before and after the start of therapy
Ga terug naar de algemene homepage Studieprotocollen.